Biossil.ai

Biossil is an AI-driven biotechnology company focused on accelerating the discovery and development of novel therapeutics. The company utilizes a proprietary computational platform that integrates deep learning and structural biology to identify high-affinity small molecule candidates for challenging biological targets. Biossil's primary focus areas include oncology and autoimmune diseases, where they aim to overcome traditional limitations in drug design. By leveraging high-throughput virtual screening and predictive modeling, the company seeks to significantly reduce the time and cost associated with early-stage drug development.